Grant: Strategic Projects - Group
McMaster University
$127,416.00
Mining marine microbial mats for bioactive secondary metabolites
EF 2011-12
Résumé
Our research will harness Canada's own natural resources to fuel the bioeconomy with a stream of bioactive
compounds to the Canadian pharmaceutical industry. Small molecules produced by microbes are a rich source
of clinical drugs widely used as treatments in infectious disease, cancer, immunosuppressive therapy, and heart
disease. This research proposal focuses on the discovery and development of bioactive compounds derived
from marine microbial mats, inhabiting some of the most extreme environments in the world and biodiverse in
Canada. We suggest that to survive and compete in such varied environments, microbes have developed
chemical defense mechanisms, which can be harnessed for human therapeutics.
A strategic network of collaborators has been gathered across Canada and the Americas to amass a collection
of giant sulphur-oxidizing marine microbes (Beggiatoa and Thioploca). From this collection, we plan to isolate
and sequence DNA, extract bioactive compounds, and develop microbial factories to produce large quantities
of medicinal compounds for pharmaceutical development in conjunction with our industrial partners.
Powerful new molecular approaches to natural products have emerged and reinvigorated the search for targeted
therapeutics from nature, and Canadian-based private industries are leaders in this field. We have formed
partnerships with two such companies, Thallion Pharmaceuticals Inc. and ACD Labs.
Leveraging the unique expertise assembled for this Strategic Program Grant will harness a new and unique
reservoir of bioactive compounds in a fashion that will greatly advance natural product discovery and
development for the benefit of the Canadian economy within the next 10 years.
The following specific aims for this grant application are:
Aim 1. Survey secondary metabolomes of Beggiatoa microbial mats
Aim 2. Heterlogous expression and microbial factories of marine metabolomes
Aim 3. Testing microbial mat secondary metabolites in extensive bioassay regimes
Programme
Strategic Projects - Group
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
385235-2009
Name nom
Magarvey, Nathan
Department département
Biochemistry and Biomedical Sciences
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2009
Award amount
127416
Program id
STPGP
Program nane en
Strategic Projects - Group
Program name fr
Projets stratégiques - De groupe
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1044
Committee name en
Strategic Projects Selection Panel - Food and Bioproducts
Committee name fr
Comité de sélection des projets stratégiques - Aliments et bioproduits
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
3701
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Natural products
Research subject fr
Produits naturels
Partie
3
Nb partie
3
Application title
Mining marine microbial mats for bioactive secondary metabolites
Keyword
NSERC
Application summary
Our research will harness Canada's own natural resources to fuel the bioeconomy with a stream of bioactive
compounds to the Canadian pharmaceutical industry. Small molecules produced by microbes are a rich source
of clinical drugs widely used as treatments in infectious disease, cancer, immunosuppressive therapy, and heart
disease. This research proposal focuses on the discovery and development of bioactive compounds derived
from marine microbial mats, inhabiting some of the most extreme environments in the world and biodiverse in
Canada. We suggest that to survive and compete in such varied environments, microbes have developed
chemical defense mechanisms, which can be harnessed for human therapeutics.
A strategic network of collaborators has been gathered across Canada and the Americas to amass a collection
of giant sulphur-oxidizing marine microbes (Beggiatoa and Thioploca). From this collection, we plan to isolate
and sequence DNA, extract bioactive compounds, and develop microbial factories to produce large quantities
of medicinal compounds for pharmaceutical development in conjunction with our industrial partners.
Powerful new molecular approaches to natural products have emerged and reinvigorated the search for targeted
therapeutics from nature, and Canadian-based private industries are leaders in this field. We have formed
partnerships with two such companies, Thallion Pharmaceuticals Inc. and ACD Labs.
Leveraging the unique expertise assembled for this Strategic Program Grant will harness a new and unique
reservoir of bioactive compounds in a fashion that will greatly advance natural product discovery and
development for the benefit of the Canadian economy within the next 10 years.
The following specific aims for this grant application are:
Aim 1. Survey secondary metabolomes of Beggiatoa microbial mats
Aim 2. Heterlogous expression and microbial factories of marine metabolomes
Aim 3. Testing microbial mat secondary metabolites in extensive bioassay regimes